The Immunoscore: Colon Cancer and Beyond.

Area of Science:

• Oncology
• Immunology
• Computational Biology

Background:

• Tumor evolution involves complex interactions with the host immune system.
• Enhancing anti-tumor immune responses can lead to significant clinical benefits.
• Understanding the tumor immune microenvironment is crucial for effective immunotherapy combinations.

Purpose of the Study:

• To review the Immunoscore and its potential as a universal characteristic for assessing tumor immune contexture.
• To explore how immune quantification combined with molecular profiling can identify patients at high risk of recurrence.
• To discuss the Immunoscore's role in predicting patient response to immunotherapies.

Main Methods:

• Review of existing literature on tumor-immune interactions and Immunoscore.
• Discussion of integrating immune cell quantification with molecular subtyping.
• Analysis of Immunoscore's potential as a predictive and prognostic biomarker.

Main Results:

• The Immunoscore offers a quantitative measure of immune infiltration within tumors.
• Combining Immunoscore with molecular data can improve risk stratification.
• Immunoscore shows promise as a tumor-agnostic biomarker for immunotherapy selection.

Conclusions:

• The Immunoscore may serve as a universal tool to define tumor immune fitness.
• It can predict and stratify patients who will benefit from immunotherapies.
• This approach has the potential to personalize cancer treatment and improve patient survival.